| October 18, 2008

In case you follow this market and missed this in the past few days – news from BioImagene.  This was discussed and rumored for some months and with previous news about Siemens executive joining BioImagene not too unexpected.  No dollar amount on the press releases I saw but fair to say even a conservative amount brings total investments since March of this year into a handful of digital pathology companies that have publicly disclosed their funding well over $100 million.   

I think the numbers are staggering considering what this market looked like just a few years ago.  Now the questions are not about image size, monitor resolution, speed…OK some of them are…but much excitement about workflow and incorporating this into the pathologist's office and enabling him/her with these technologies. 

With GE and Siemens in the market, this is encouraging for all pathologists.  I suspect news coming from Phillips is not far behind.

"Digital pathology company BioImagene Inc. said Thursday it received an investment from Siemens Venture Capital.

Cupertino-based BioImagene did not disclose the amount of the investment, but said it follows a recent closing of a $26 million fourth round.

Semens Venture Capital, which has an office in Palo Alto, is the corporate venture organization for Siemens AG, one of the largest global electronics and engineering companies.

BioImagene's funders also include San Francisco-based Burrill & Co., St. Louis, Mo.-based Ascension Health Ventures, National Healthcare Services, Palo Alto-based Artiman Ventures and ICCP Ventures.

Digital pathology is the process of converting entire glass microscope slides into high-resolution, whole-slide digital images that can be viewed, managed and analyzed with a computer instead of a microscope."


Category: Digital Pathology News, Pathology News

Comments are closed.